- Home
- ARMP vs UPLD Comparison
ARMP vs UPLD Comparison
Compare ARMP & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- UPLD
- Stock Information
- Founded
- ARMP N/A
- UPLD 2010
- Country
- ARMP United States
- UPLD United States
- Employees
- ARMP N/A
- UPLD N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- UPLD Computer Software: Prepackaged Software
- Sector
- ARMP Health Care
- UPLD Technology
- Exchange
- ARMP Nasdaq
- UPLD Nasdaq
- Market Cap
- ARMP 52.1M
- UPLD 51.0M
- IPO Year
- ARMP N/A
- UPLD 2014
- Fundamental
- Price
- ARMP $2.22
- UPLD $1.93
- Analyst Decision
- ARMP Strong Buy
- UPLD Hold
- Analyst Count
- ARMP 1
- UPLD 1
- Target Price
- ARMP $9.00
- UPLD N/A
- AVG Volume (30 Days)
- ARMP 18.4K
- UPLD 101.3K
- Earning Date
- ARMP 08-12-2025
- UPLD 07-31-2025
- Dividend Yield
- ARMP N/A
- UPLD N/A
- EPS Growth
- ARMP N/A
- UPLD N/A
- EPS
- ARMP N/A
- UPLD N/A
- Revenue
- ARMP $4,699,000.00
- UPLD $267,713,000.00
- Revenue This Year
- ARMP $8.43
- UPLD N/A
- Revenue Next Year
- ARMP N/A
- UPLD N/A
- P/E Ratio
- ARMP N/A
- UPLD N/A
- Revenue Growth
- ARMP 14.24
- UPLD N/A
- 52 Week Low
- ARMP $0.90
- UPLD $1.69
- 52 Week High
- ARMP $3.42
- UPLD $5.64
- Technical
- Relative Strength Index (RSI)
- ARMP 63.56
- UPLD 48.12
- Support Level
- ARMP $1.93
- UPLD $1.90
- Resistance Level
- ARMP $2.24
- UPLD $2.08
- Average True Range (ATR)
- ARMP 0.16
- UPLD 0.11
- MACD
- ARMP 0.03
- UPLD 0.03
- Stochastic Oscillator
- ARMP 104.55
- UPLD 59.21
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.